CEO Jason Hollar was paid $22,574,349 in fiscal year 2026, ↑ up 19.0% from fiscal year 2025, the 50th percentile of its disclosed peer group (SEC filing 0001308179-26-000402 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
$22,574,349 ↑ Jason Hollar total, FY2026 | 50th CEO pay percentile vs peers | 288:1 CEO-to-median pay ratio | 90.7% Say-on-pay support, latest vote |
Track this company's pay every filing: join the Pro seat waitlist
Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year
Ask our research desk — $99, 24h, every figure cited to its filing.
CAH's next annual pay disclosure, estimated September 21, 2027.est. Filing ↗
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Jason Hollar | $1,500,000 | $0 | $16,259,918 | $0 | $4,278,750 | $0 | $535,681 | $22,574,349 |
| Chief Executive Officer | ||||||||
| Aaron Alt | 896,233 | 0 | 4,318,999 | 0 | 1,606,945 | 0 | 37,996 | 6,860,173 |
| Chief Financial Officer | ||||||||
| Deborah Weitzman | 770,479 | 0 | 4,064,943 | 0 | 1,254,340 | 0 | 30,395 | 6,120,157 |
| Chief Executive Officer, Pharmaceutical and Specialty Solutions Segment | ||||||||
| Jessica Mayer | 741,233 | 0 | 3,556,822 | 0 | 1,208,210 | 0 | 27,918 | 5,534,183 |
| Chief Legal and Compliance Officer | ||||||||
| Stephen Mason | 761,986 | 0 | 3,404,479 | 0 | 1,112,500 | 0 | 14,400 | 5,293,365 |
| Chief Executive Officer, Global Medical Products and Distribution Segment | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2026 total | FY2025 total | FY2024 total | Δ FY2025→2026 |
|---|---|---|---|---|
| Jason Hollar | $22,574,349 | $18,976,195 | $25,651,209 | ↑ +3,598,154 |
| Aaron Alt | 6,860,173 | 6,210,035 | 6,842,901 | ↑ +650,138 |
| Deborah Weitzman | 6,120,157 | 5,507,857 | 5,088,847 | ↑ +612,300 |
| Jessica Mayer | 5,534,183 | 4,925,352 | 4,657,765 | ↑ +608,831 |
| Stephen Mason | 5,293,365 | 4,745,044 | 7,337,813 | ↑ +548,321 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
You have just read Cardinal Health's Summary Compensation Table. The whole free brief as a PDF, emailed now, with every figure cited — then a few short notes on the deeper CAH reports.
We send the PDF right away, then up to three short notes. Reply “unsubscribe” to any of them, any time.
How we handle your data → Privacy
Each company listed discloses CAH in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named CAH in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
One page per director: the seat, the committees and the fee table, read for one person at a time.
| Director | Role | FY2026 total |
|---|---|---|
| Akhil Johri | Independent Director | $358,277 |
| Christine A. Mundkur | Independent Director | $333,114 |
| David C. Evans | Independent Director | $366,089 |
| Gregory B. Kenny | Former director (through FY2026) | $532,937 |
| Michelle M. Brennan | Independent Director | $352,122 |
| Nancy Killefer | Independent Director | $376,252 |
| Patricia A. Hemingway Hall | Chair of the Board | $471,844 |
| Robert W. Azelby | Independent Director | $353,114 |
| Robert W. Musslewhite | Independent Director | $353,114 |
| Sheri H. Edison | Independent Director | $376,252 |
| Sudhakar Ramakrishna | Independent Director | $353,114 |
No insider equity transactions reported since the proxy statement.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Stephen Mason | PSU | 110,004 | — | $26,132,550 |
| Jason Hollar | PSU | 460,863 | — | 109,482,614 |
| Aaron Alt | PSU | 135,640 | — | 32,222,638 |
| Deborah Weitzman | PSU | 127,497 | — | 30,288,187 |
| Jessica Mayer | PSU | 109,538 | — | 26,021,847 |
| Jason Hollar | RSU | 92,603 | — | 21,998,769 |
| Aaron Alt | RSU | 26,408 | — | 6,273,484 |
| Deborah Weitzman | RSU | 24,132 | — | 5,732,798 |
| Jessica Mayer | RSU | 20,873 | — | 4,958,590 |
| Stephen Mason | RSU | 20,819 | — | 4,945,762 |
Our executive compensation program is designed to support our long-term growth, with accountability for key annual results. It emphasizes performance and retention using long-term, stock-based incentive compensation to align executive interests with shareholders, while maintaining a competitive program to attract and retain critical talent.
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Korn Ferry |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | true |
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2025 | 2025-11-05 | 168,382,554 | 17,271,117 | 1,513,298 | 90.7% | Passed |
| 2024 | 2024-11-06 | 172,738,569 | 19,964,307 | 516,807 | 89.64% | Passed |
| 2023 | 2023-11-15 | 182,671,067 | 16,863,757 | 618,935 | 91.55% | Passed |
| 2022 | 2022-11-09 | 184,983,772 | 18,266,030 | 946,572 | 91.01% | Passed |
| 2021 | 2021-11-05 | 194,218,187 | 31,712,173 | 514,906 | 85.77% | Passed |
| 2020 | 2020-11-04 | 142,613,827 | 89,768,639 | 568,367 | 61.22% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.
| Meeting year | Meeting date | Approval — company's computation |
|---|---|---|
| 2025 | 2025-11-05 | 90.7%a |
| 2024 | 2024-11-06 | 89.64%b |
| 2023 | 2023-11-15 | 91.55%c |
a. Approved under the standard stated in the filing — “Each of the proposals requires approval by a majority of votes cast.”.
b. Approved under the standard stated in the filing — “Abstentions and broker non-votes are not considered as votes cast and will not be counted in determining the outcome of the voting results.”.
c. Approved under the standard stated in the filing — “Abstentions and broker non-votes are not considered as votes cast and will not be counted in determining the outcome of the voting results.”.
Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
| Ratio (CEO : median employee) | 288 : 1 |
|---|---|
| CEO total compensation | $22,574,349 |
| Median employee compensation | $78,316 |
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Gregory B. KennyIndependent · Not standing for re-election · Departed during FY | $178,000 | $334,937 | — | — | $20,000 | $532,937 |
| Patricia A. Hemingway HallIndependent · Board Chair · Governance and Sustainability | 162,686 | 289,158 | — | — | 20,000 | 471,844 |
| Nancy KilleferIndependent · Governance and Sustainability · Human Resources and Compensation | 146,277 | 209,975 | — | — | 20,000 | 376,252 |
| Sheri H. EdisonIndependent · Governance and Sustainability · Risk Oversight (Chair) | 146,277 | 209,975 | — | — | 20,000 | 376,252 |
| David C. EvansIndependent · Audit (Chair) · Human Resources and Compensation | 146,114 | 209,975 | — | — | 10,000 | 366,089 |
| Akhil JohriIndependent · Audit · Governance and Sustainability | 128,302 | 209,975 | — | — | 20,000 | 358,277 |
| Robert W. MusslewhiteIndependent · Human Resources and Compensation (Chair) · Risk Oversight | 123,139 | 209,975 | — | — | 20,000 | 353,114 |
| Robert W. AzelbyIndependent · Audit · Human Resources and Compensation | 123,139 | 209,975 | — | — | 20,000 | 353,114 |
| Sudhakar RamakrishnaIndependent · Audit · Risk Oversight | 123,139 | 209,975 | — | — | 20,000 | 353,114 |
| Michelle M. BrennanIndependent · Governance and Sustainability (Chair) · Human Resources and Compensation | 142,147 | 209,975 | — | — | 0 | 352,122 |
| Christine A. MundkurIndependent · Audit · Risk Oversight | 123,139 | 209,975 | — | — | 0 | 333,114 |
| Jason M. HollarEmployee director | — | — | — | — | — | 0 |
| Annual cash retainer | $125,000 |
|---|---|
| Annual equity retainer | $210,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 30,000 / 25,000 / 25,000 |
| Stock ownership guideline | $5 |
| Component | FY2026 |
|---|---|
| Cash retainers and fees | $1,542,359 |
| Equity awards (grant-date value) | $2,513,870 |
| All other compensation | $170,000 |
| Total cost of the board | $4,226,229 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
Of the companies Cardinal Health names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including Cardinal Health.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific Inc. | 2025 | Marc Casper | $1,785,534 | $65,730,211 | $7,951,377 | $3,742,123 | $79,923,350 |
| 2 | UnitedHealth Group Incorporated | 2025 | Stephen Hemsley | 596,154 | 0 | 60,000,024 | 0 | 60,938,062 |
| 3 | Johnson & Johnson | 2025 | Joaquin Duato | 1,600,000 | 15,028,948 | 5,927,995 | 4,298,700 | 32,758,111 |
| 4 | Baxter International Inc. | 2025 | Andrew Hider | 499,315 | 23,133,518 | 3,185,053 | 820,125 | 29,805,182 |
| 5 | FedEx Corporation | 2026 | Rajesh Subramaniam | 1,550,000 | 6,731,364 | 3,715,062 | 10,593,500 | 27,554,018 |
| 6 | McKesson Corporation | 2026 | Brian Tyler | 1,591,667 | 17,201,202 | 0 | 4,456,668 | 24,213,044 |
| 7 | Danaher Corporation | 2025 | Rainer Blair | 1,400,000 | 9,292,370 | 8,386,657 | 4,194,400 | 23,795,280 |
| 8 | Boston Scientific Corporation | 2025 | Michael Mahoney | 1,442,603 | 13,608,056 | 3,749,980 | 4,002,001 | 23,532,050 |
| 9 | United Parcel Service, Inc. | 2025 | Carol Tomé | 1,509,713 | 17,550,546 | 1,358,754 | 2,264,569 | 22,878,788 |
| 10 | The Cigna Group | 2025 | David Cordani | 1,600,000 | 13,929,161 | 3,400,019 | 3,200,000 | 22,866,134 |
| 11 | Elevance Health, Inc. | 2025 | Gail Boudreaux | 1,600,000 | 13,440,277 | 4,199,765 | 2,768,000 | 22,582,314 |
| 12 | Cardinal Health | 2026 | Jason Hollar | 1,500,000 | 16,259,918 | 0 | 4,278,750 | 22,574,349 |
| 13 | Stryker Corporation | 2025 | Kevin Lobo | 1,500,000 | 9,764,136 | 6,920,781 | 2,250,000 | 21,401,495 |
| 14 | CVS Health Corporation | 2025 | J. David Joyner | 1,500,000 | 14,499,931 | 0 | 4,695,900 | 21,214,084 |
| 15 | Labcorp Holdings Inc. | 2025 | Adam Schechter | 1,435,000 | 11,400,463 | 2,754,582 | 2,062,095 | 18,339,913 |
| 16 | Cencora, Inc. | 2025 | Robert Mauch | 1,350,000 | 12,000,218 | 0 | 4,283,213 | 18,256,227 |
| 17 | Sysco Corporation | 2026 | Kevin Hourican | 1,435,538 | 10,391,759 | 2,579,986 | 2,905,602 | 17,899,369 |
| 18 | Becton, Dickinson and Company | 2025 | Thomas Polen | 1,395,463 | 9,991,854 | 3,311,861 | 1,852,010 | 17,129,140 |
| 19 | The Kroger Co. | 2025 | Ronald L. Sargent | 3,975,806 | 10,000,077 | — | — | 14,037,608 |
| 20 | Walgreens Boots Alliance, Inc. | 2024 | Timothy Wentworth | 1,290,385 | 11,600,744 | 0 | 0 | 13,282,800 |
| 21 | Henry Schein, Inc. | 2025 | Stanley Bergman | 1,707,000 | 7,764,800 | 0 | 2,289,251 | 12,013,915 |
| 22 | Accendra Health, Inc. | 2025 | Edward Pesicka | 1,150,000 | 9,560,140 | — | 345,000 | 11,157,809 |
| 23 | Target Corporation | 2025 | Michael Fiddelke | 1,065,385 | 7,853,253 | 0 | 300,882 | 9,598,071 |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| Cardinal Health | not disclosed | PSU 60 · RSU 40 | Yes — Relative TSR modifier | Korn Ferry |
| Accendra Health, Inc. | 20% | RSU 50 · PSU 50 | not disclosed | Frederic W. Cook & Co., Inc. (FW Cook) |
| Baxter International Inc. | not disclosed | not disclosed | No | Aon Consulting, Inc. (Aon) |
| Becton, Dickinson and Company | 85% | PSU 50 · Options 25 · RSU 25 | No | Semler Brossy |
| Boston Scientific Corporation | 173% | PSU 50 · RSU 25 · Options 25 | No | Semler Brossy Consulting Group, LLC |
| Cencora, Inc. | 181.3% | PSU 60 · RSU 40 | Yes — Relative TSR | Pearl Meyer & Partners |
| CVS Health Corporation | 156.5% | PSU 60 · RSU 20 · Options 20 | Yes — rTSR Modifier | Korn Ferry |
| Danaher Corporation | not disclosed | Options 50 · RSU 50 | Yes — Relative TSR | FW Cook |
| Elevance Health, Inc. | 86.5% | PSU 52 · RSU 24 · Options 24 | No | Willis Towers Watson (WTW) |
| FedEx Corporation | 112.5% | not disclosed | Yes — Relative TSR (FY24-FY26 LTI Cash Plan) | Meridian Compensation Partners, LLC |
| Henry Schein, Inc. | 89.3% | PSU 65 · RSU 35 | No | Pearl Meyer |
| Johnson & Johnson | not disclosed | not disclosed | Yes — Relative TSR | Semler Brossy Consulting Group |
| Labcorp Holdings Inc. | 95.8% | PSU 60 · RSU 20 · Options 20 | Yes — RELATIVE TSR MODIFIER | FW Cook |
| McKesson Corporation | 140% | PSU 60 · RSU 40 | Yes — Total Shareholder Return (TSR) relative to comparator group | Korn Ferry |
| Stryker Corporation | 100% | PSU 48 · Options 34 | No | Semler Brossy |
| Sysco Corporation | 115.66% | PSU 50 · RSU 30 · Option 20 | No | Semler Brossy |
| Target Corporation | not disclosed | PSU 60 · PBRSU 40 | No | Semler Brossy |
| The Cigna Group | 100% | PSU 60 · RSU 20 · Options 20 | No | Pay Governance |
| The Kroger Co. | 93.84% | not disclosed | Yes — Value creation (iTSR) | Korn Ferry; Meridian Compensation Partners, LLC |
| Thermo Fisher Scientific Inc. | 99.8% | PSU 50 · Options 50 | Yes — Relative TSR | Pearl Meyer |
| United Parcel Service, Inc. | 75% | PSU 93 · Options 7 | Yes — Relative Total Shareowner Return (RTSR) | FW Cook |
| UnitedHealth Group Incorporated | not disclosed | PSU 50 · Options 25 · RSU 25 | No | Pay Governance |
| Walgreens Boots Alliance, Inc. | not disclosed | RSU 100 | not disclosed | Mercer |
Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Jason Hollar | DEF 14A | 2026-09-21 | 0001308179-26-000402 | Section “Executive Compensation Tables” · page 58. As printed: 22,574,349. Filing ↗machine: r2 · c21 · span 1230025–1230035 |
| 2 | Section 01, Aaron Alt | DEF 14A | 2026-09-21 | 0001308179-26-000402 | Section “Executive Compensation Tables” · page 58. As printed: 6,860,173. Filing ↗machine: r5 · c21 · span 1239396–1239405 |
| 3 | Section 01, Deborah Weitzman | DEF 14A | 2026-09-21 | 0001308179-26-000402 | Section “Executive Compensation Tables” · page 58. As printed: 6,120,157. Filing ↗machine: r11 · c21 · span 1258181–1258190 |
| 4 | Section 01, Jessica Mayer | DEF 14A | 2026-09-21 | 0001308179-26-000402 | Section “Executive Compensation Tables” · page 58. As printed: 5,534,183. Filing ↗machine: r14 · c21 · span 1267606–1267615 |
| 5 | Section 01, Stephen Mason | DEF 14A | 2026-09-21 | 0001308179-26-000402 | Section “Executive Compensation Tables” · page 58. As printed: 5,293,365. Filing ↗machine: r8 · c21 · span 1248751–1248760 |
| 6 | Section 07, pay ratio | DEF 14A | 2026-09-21 | 0001308179-26-000402 | Section “CEO Pay Ratio”. As printed: 288 : 1. Filing ↗machine: span 1600108–1600111 |
| 7 | Section 08, Gregory B. Kenny | DEF 14A | 2026-09-21 | 0001308179-26-000402 | Section “Director Compensation”. As printed: 532,937. Filing ↗machine: span 817314–817565 |
| 8 | Section 08, Patricia A. Hemingway Hall | DEF 14A | 2026-09-21 | 0001308179-26-000402 | Section “Director Compensation”. As printed: 471,844. Filing ↗machine: span 813270–813521 |
| 9 | Section 08, Nancy Killefer | DEF 14A | 2026-09-21 | 0001308179-26-000402 | Section “Director Compensation”. As printed: 376,252. Filing ↗machine: span 819113–819364 |
| 10 | Section 08, Sheri H. Edison | DEF 14A | 2026-09-21 | 0001308179-26-000402 | Section “Director Compensation”. As printed: 376,252. Filing ↗machine: span 809409–809660 |
| 11 | Section 08, David C. Evans | DEF 14A | 2026-09-21 | 0001308179-26-000402 | Section “Director Compensation”. As printed: 366,089. Filing ↗machine: span 811208–811459 |
| 12 | Section 08, Akhil Johri | DEF 14A | 2026-09-21 | 0001308179-26-000402 | Section “Director Compensation”. As printed: 358,277. Filing ↗machine: span 815066–815317 |
| 13 | Section 08, Robert W. Musslewhite | DEF 14A | 2026-09-21 | 0001308179-26-000402 | Section “Director Compensation”. As printed: 353,114. Filing ↗machine: span 822703–822954 |
| 14 | Section 08, Robert W. Azelby | DEF 14A | 2026-09-21 | 0001308179-26-000402 | Section “Director Compensation”. As printed: 353,114. Filing ↗machine: span 805808–806057 |
| 15 | Section 08, Sudhakar Ramakrishna | DEF 14A | 2026-09-21 | 0001308179-26-000402 | Section “Director Compensation”. As printed: 353,114. Filing ↗machine: span 824764–825047 |
| 16 | Section 08, Michelle M. Brennan | DEF 14A | 2026-09-21 | 0001308179-26-000402 | Section “Director Compensation”. As printed: 352,122. Filing ↗machine: span 807609–807860 |
| 17 | Section 08, Christine A. Mundkur | DEF 14A | 2026-09-21 | 0001308179-26-000402 | Section “Director Compensation”. As printed: 333,114. Filing ↗machine: span 820908–821159 |
| 18 | Section 08, Jason M. Hollar | DEF 14A | 2026-09-21 | 0001308179-26-000402 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 19 | Section 06, 2025 vote | Form 8-K | 2025-11-06 | 0000721371-25-000133 | Item 5.07 · say-on-pay result. As reported: 90.7% (votes for as printed: 168,382,554). Filing ↗ |
| 20 | Section 06, 2024 vote | Form 8-K | 2024-11-07 | 0000721371-24-000132 | Item 5.07 · say-on-pay result. As reported: 89.64% (votes for as printed: 172,738,569). Filing ↗ |
| 21 | Section 06, 2023 vote | Form 8-K | 2023-11-16 | 0000721371-23-000094 | Item 5.07 · say-on-pay result. As reported: 91.55% (votes for as printed: 182,671,067). Filing ↗ |
| 22 | Section 01 trend, Δ column (computed) | Computed | — | — | Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1) |
| 23 | Section 09b board cost (computed) | Computed | — | — | Cash 1,542,359 + equity 2,513,870 + all other 170,000 = 4,226,229, summed across the director compensation table rows.machine: formula: Σ = 4,226,229 |
| 24 | Thermo Fisher Scientific Inc., Section 10b CEO total | DEF 14A | 2026-04-07 | 0001193125-26-144585 | CEO total compensation as printed in Thermo Fisher Scientific Inc.'s own proxy. As printed: 79,923,350. Filing ↗machine: span 973487–973497 |
| 25 | UnitedHealth Group Incorporated, Section 10b CEO total | DEF 14A | 2026-04-21 | 0001104659-26-046125 | CEO total compensation as printed in UnitedHealth Group Incorporated's own proxy. As printed: 60,938,062. Filing ↗machine: r1 · c48 · span 1832651–1832661 |
| 26 | Johnson & Johnson, Section 10b CEO total | DEF 14A | 2026-03-11 | 0000200406-26-000063 | CEO total compensation as printed in Johnson & Johnson's own proxy. As printed: 32,758,111. Filing ↗machine: r3 · c27 · span 1621235–1621246 |
| 27 | Baxter International Inc., Section 10b CEO total | DEF 14A | 2026-03-23 | 0001628280-26-020330 | CEO total compensation as printed in Baxter International Inc.'s own proxy. As printed: 29,805,182. Filing ↗machine: r4 · c30 · span 1451066–1451076 |
| 28 | FedEx Corporation, Section 10b CEO total | DEF 14A | 2026-08-17 | 0001104659-26-097836 | CEO total compensation as printed in FedEx Corporation's own proxy. As printed: 27,554,018. Filing ↗machine: r1 · c54 · span 1409491–1409501 |
| 29 | McKesson Corporation, Section 10b CEO total | DEF 14A | 2026-06-12 | 0000927653-26-000169 | CEO total compensation as printed in McKesson Corporation's own proxy. As printed: 24,213,044. Filing ↗machine: r2 · c21 · span 1260172–1260182 |
| 30 | Danaher Corporation, Section 10b CEO total | DEF 14A | 2026-03-25 | 0000313616-26-000101 | CEO total compensation as printed in Danaher Corporation's own proxy. As printed: 23,795,280. Filing ↗machine: t122 · r2 · c21 · span 1070180–1070190 |
| 31 | Boston Scientific Corporation, Section 10b CEO total | DEF 14A | 2026-03-18 | 0000885725-26-000025 | CEO total compensation as printed in Boston Scientific Corporation's own proxy. As printed: 23,532,050. Filing ↗machine: r2 · c27 · span 1249807–1249817 |
| 32 | United Parcel Service, Inc., Section 10b CEO total | DEF 14A | 2026-03-19 | 0001628280-26-019856 | CEO total compensation as printed in United Parcel Service, Inc.'s own proxy. As printed: 22,878,788. Filing ↗machine: r2 · c27 · span 899122–899132 |
| 33 | The Cigna Group, Section 10b CEO total | DEF 14A | 2026-03-13 | 0001739940-26-000023 | CEO total compensation as printed in The Cigna Group's own proxy. As printed: 22,866,134. Filing ↗machine: t303 · r3 · c16 · span 1360729–1360739 |
| 34 | Elevance Health, Inc., Section 10b CEO total | DEF 14A | 2026-03-27 | 0001156039-26-000031 | CEO total compensation as printed in Elevance Health, Inc.'s own proxy. As printed: 22,582,314. Filing ↗machine: span 1161376–1161386 |
| 35 | Cardinal Health (subject), Section 10b CEO total | DEF 14A | 2026-09-21 | 0001308179-26-000402 | CEO total compensation as printed in Cardinal Health's own proxy. As printed: 22,574,349. Filing ↗machine: r2 · c21 · span 1230025–1230035 |
| 36 | Stryker Corporation, Section 10b CEO total | DEF 14A | 2026-03-23 | 0000310764-26-000013 | CEO total compensation as printed in Stryker Corporation's own proxy. As printed: 21,401,495. Filing ↗machine: t101 · r2 · c7 · span 1584979–1584989 |
| 37 | CVS Health Corporation, Section 10b CEO total | DEF 14A | 2026-04-03 | 0001308179-26-000201 | CEO total compensation as printed in CVS Health Corporation's own proxy. As printed: 21,214,084. Filing ↗machine: r1 · c18 · span 969864–969874 |
| 38 | Labcorp Holdings Inc., Section 10b CEO total | DEF 14A | 2026-04-10 | 0001193125-26-150752 | CEO total compensation as printed in Labcorp Holdings Inc.'s own proxy. As printed: 18,339,913. Filing ↗machine: t153 · r3 · c22 · span 3147696–3147706 |
| 39 | Cencora, Inc., Section 10b CEO total | DEF 14A | 2026-01-22 | 0001628280-26-003061 | CEO total compensation as printed in Cencora, Inc.'s own proxy. As printed: 18,256,227. Filing ↗machine: r2 · c18 · span 1212336–1212346 |
| 40 | Sysco Corporation, Section 10b CEO total | DEF 14A | 2026-10-01 | 0000096021-26-000037 | CEO total compensation as printed in Sysco Corporation's own proxy. As printed: 17,899,369. Filing ↗machine: r2 · c9 · span 2096793–2096803 |
| 41 | Becton, Dickinson and Company, Section 10b CEO total | DEF 14A | 2025-12-18 | 0001628280-25-057846 | CEO total compensation as printed in Becton, Dickinson and Company's own proxy. As printed: 17,129,140. Filing ↗machine: r2 · c27 · span 1173285–1173295 |
| 42 | The Kroger Co., Section 10b CEO total | DEF 14A | 2026-05-13 | 0001104659-26-060250 | CEO total compensation as printed in The Kroger Co.'s own proxy. As printed: 14,037,608. Filing ↗machine: t229 · r1 · c9 · span 692555–692565 |
| 43 | Walgreens Boots Alliance, Inc., Section 10b CEO total | DEF 14A | 2024-12-13 | 0001558370-24-016214 | CEO total compensation as printed in Walgreens Boots Alliance, Inc.'s own proxy. As printed: 13,282,800. Filing ↗machine: r11 · c18 · span 2265448–2265458 |
| 44 | Henry Schein, Inc., Section 10b CEO total | DEF 14A | 2026-04-08 | 0001193125-26-146317 | CEO total compensation as printed in Henry Schein, Inc.'s own proxy. As printed: 12,013,915. Filing ↗machine: t221 · r3 · c35 · span 671366–671376 |
| 45 | Accendra Health, Inc., Section 10b CEO total | DEF 14A | 2026-04-02 | 0001104659-26-038823 | CEO total compensation as printed in Accendra Health, Inc.'s own proxy. As printed: 11,157,809. Filing ↗ |
| 46 | Target Corporation, Section 10b CEO total | DEF 14A | 2026-04-27 | 0001628280-26-027508 | CEO total compensation as printed in Target Corporation's own proxy. As printed: 9,598,071. Filing ↗machine: r7 · c8 · span 2799507–2799517 |
| 47 | Section 10a, Cencora, Inc. reciprocity | DEF 14A | — | 0001628280-26-003061 | Cencora, Inc. names Cardinal Health in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 48 | Section 10a, Walgreens Boots Alliance, Inc. reciprocity | DEF 14A | — | 0001558370-24-016214 | Walgreens Boots Alliance, Inc.'s most recent proxy was read; its disclosed peer group does not include Cardinal Health. Filing ↗ |
| 49 | Section 10a, United Parcel Service, Inc. reciprocity | DEF 14A | — | 0001628280-26-019856 | United Parcel Service, Inc.'s most recent proxy was read; its disclosed peer group does not include Cardinal Health. Filing ↗ |
| 50 | Section 10a, Elevance Health, Inc. reciprocity | DEF 14A | — | 0001156039-26-000031 | Elevance Health, Inc. names Cardinal Health in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 51 | Section 10a, Baxter International Inc. reciprocity | DEF 14A | — | 0001628280-26-020330 | Baxter International Inc.'s most recent proxy was read; its disclosed peer group does not include Cardinal Health. Filing ↗ |
| 52 | Section 10a, McKesson Corporation reciprocity | DEF 14A | — | 0000927653-26-000169 | McKesson Corporation's most recent proxy was read; its disclosed peer group does not include Cardinal Health. Filing ↗ |
| 53 | Section 10a, The Cigna Group reciprocity | DEF 14A | — | 0001739940-26-000023 | The Cigna Group names Cardinal Health in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 54 | Section 10a, Labcorp Holdings Inc. reciprocity | DEF 14A | — | 0001193125-26-150752 | Labcorp Holdings Inc.'s most recent proxy was read; its disclosed peer group does not include Cardinal Health. Filing ↗ |
| 55 | Section 10a, UnitedHealth Group Incorporated reciprocity | DEF 14A | — | 0001104659-26-046125 | UnitedHealth Group Incorporated names Cardinal Health in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 56 | Section 10a, Henry Schein, Inc. reciprocity | DEF 14A | — | 0001193125-26-146317 | Henry Schein, Inc. names Cardinal Health in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 57 | Section 10a, Johnson & Johnson reciprocity | DEF 14A | — | 0000200406-26-000063 | Johnson & Johnson's most recent proxy was read; its disclosed peer group does not include Cardinal Health. Filing ↗ |
| 58 | Section 10a, Target Corporation reciprocity | DEF 14A | — | 0001628280-26-027508 | Target Corporation's most recent proxy was read; its disclosed peer group does not include Cardinal Health. Filing ↗ |
| 59 | Section 10a, Stryker Corporation reciprocity | DEF 14A | — | 0000310764-26-000013 | Stryker Corporation's most recent proxy was read; its disclosed peer group does not include Cardinal Health. Filing ↗ |
| 60 | Section 10a, Boston Scientific Corporation reciprocity | DEF 14A | — | 0000885725-26-000025 | Boston Scientific Corporation's most recent proxy was read; its disclosed peer group does not include Cardinal Health. Filing ↗ |
| 61 | Section 10a, Danaher Corporation reciprocity | DEF 14A | — | 0000313616-26-000101 | Danaher Corporation's most recent proxy was read; its disclosed peer group does not include Cardinal Health. Filing ↗ |
| 62 | Section 10a, Sysco Corporation reciprocity | DEF 14A | — | 0000096021-26-000037 | Sysco Corporation's most recent proxy was read; its disclosed peer group does not include Cardinal Health. Filing ↗ |
| 63 | Section 10a, Becton, Dickinson and Company reciprocity | DEF 14A | — | 0001628280-25-057846 | Becton, Dickinson and Company's most recent proxy was read; its disclosed peer group does not include Cardinal Health. Filing ↗ |
| 64 | Section 10a, Accendra Health, Inc. reciprocity | DEF 14A | — | 0001104659-26-038823 | Accendra Health, Inc.'s most recent proxy was read; its disclosed peer group does not include Cardinal Health. Filing ↗ |
The Pay Desk — the free weekly executive pay briefing, one company at a time, every number traceable to a public filing.
You'll confirm on The Pay Desk's sign-up page.